January 21, 2025, Tokyo, Japan: MEDIROM Healthcare technologies Inc. (NASDAQ: MRM) (“MEDIROM”), a health technology and holistic healthcare company headquartered in Tokyo, Japan and led by CEO Kouji Eguchi, is pleased to announce that its subsidiary, MEDIROM MOTHER Labs Inc. (“MOTHER Labs”) is now providing its remote health monitoring system, REMONY, and charging-free smart tracker device, MOTHER Bracelet®︎, to the Electronics Division of TOPPAN Inc. (Tokyo Stock Exchange:  7911). In recent years, employee health management has shifted from being an individual’s responsibility to becoming one of the key priorities for companies. Since their founding, TOPPAN has consistently undertaken various initiatives to ensure the physical and mental well-being of their employees based on the core philosophy of respect for human beings. As part of TOPPAN’s efforts to promote employee health, creating a safe and secure living environment for employees living alone, such as those on solo assignments, has been one of the key initiatives. By utilizing REMONY, TOPPAN aims to establish an environment that enables early detection and prompt responses in the event of certain health abnormalities.  About the MOTHER Bracelet, Recharge-Free Smart Tracker<figure><img src="https://images.microcms-assets.io/assets/9edf8dbea622483096fe2cacad989656/cd1ccbb1e9404f6d858234d24cabfb7d/1746.jpg" alt="" width="1920" height="1080"></figure> MOTHER Bracelet is the world&apos;s first 24/7 recharge-free smart tracker, powered by advanced technology that generates electricity from the temperature difference between the body and the surrounding air. As it doesn&apos;t require recharging, it eliminates the data loss that can occur when a device is taken off for recharging. This single device can record five fundamental health metrics: heart rate, surface body temperature, step count, sleep, and calories burned. <a href="https://mother-bracelet.com">https://mother-bracelet.com</a> About Remote Health Monitoring System - REMONY<figure><img src="https://images.microcms-assets.io/assets/9edf8dbea622483096fe2cacad989656/62c6cbe9e2254e13a8cfd8d1a7f8f02d/2173.jpg" alt="" width="1920" height="1080"></figure> &apos;REMONY&apos; remote health monitoring system, developed by MEDIROM MOTHER Labs, combines the wrist-worn recharge-free smart tracker MOTHER Bracelet with a dedicated gateway. The system enables automatic data synchronization and centralized real-time management. Health monitoring with conventional wearables often faces challenges due to data loss during device recharge period. However, MOTHER Bracelet measures user vital data in real-time 24/7 without needing removal for recharge. As a result, it allows prompt and early detection of health emergencies and accident prevention with high accuracy. The system is customizable for use in various industries, including elderly care, health monitoring for night shift workers, etc. About MEDIROM Healthcare Technologies Inc. MEDIROM, a holistic healthcare company, operates over 300 wellness salons across Japan, Re.Ra.Ku®︎ being its leading brand, and provides healthcare services. In 2015, MEDIROM entered the health tech business and launched new healthcare programs using an on-demand training app called “Lav®︎”, which is developed by MEDIROM. MEDIROM also entered the device business in 2020 and has developed a smart tracker “MOTHER Bracelet®︎”. In 2023, MEDIROM launched REMONY, a remote monitoring system for corporate clients, and has received orders from a broad range of industries, including nursing care, transportation, construction, and manufacturing, among others. MEDIROM hopes that its diverse health-related product and service offerings will help it collect and manage healthcare data from users and customers and enable it to become a leader in big data in the healthcare industry. For more information, visit <a href="https://medirom.co.jp/en">https://medirom.co.jp/en</a> Contact:Investor Relations TeamE-mail:ir@medirom.co.jp About TOPPAN Inc. <figure><img src="https://images.microcms-assets.io/assets/9edf8dbea622483096fe2cacad989656/bc1c19ade98d4bd9baeae05e5d0bc9ae/2214.png" alt="" width="1577" height="262"></figure> TOPPAN Inc. develops solutions based on its printing technologies in Japan and internationally. It operates through three business segments: Information &amp; Communication, Living &amp; Industry, and Electronics. Its Information &amp; Communication business offers securities, passbooks, cards, business forms, catalogs, and printed advertising media, as well as printed publication media, such as magazines and books, and business process outsourcing. The Living &amp; Industry business provides packaging, including flexible packaging materials and folding cartons, rigid plastic products, inks, and transparent barrier films; and decor materials, such as decorative sheets and wallpapers. Its Electronics business offers LCD color filters, TFT-LCDs, antireflection films, photomasks, and semiconductor package products. TOPPAN Inc. is the core operating company of the TOPPAN Group, which was reorganized into a holding company structure in October 2023, 123 years after Toppan Printing was founded in Tokyo in 1900. <a href="https://www.toppan.com/en/">https://www.toppan.com/en</a> Forward-Looking Statements Regarding MEDIROM Certain statements in this press release are forward-looking statements for purposes of the safe harbor provisions under the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements may include estimates or expectations about MEDIROM’s possible or assumed operational results, financial condition, business strategies and plans, market opportunities, competitive position, industry environment, and potential growth opportunities. In some cases, forward-looking statements can be identified by terms such as “may,” “will,” “should,” “design,” “target,” “aim,” “hope,” “expect,” “could,” “intend,” “plan,” “anticipate,” “estimate,” “believe,” “continue,” “predict,” “project,” “potential,” “goal,” or other words that convey the uncertainty of future events or outcomes. These statements relate to future events or to MEDIROM’s future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause MEDIROM’s actual results, levels of activity, performance, or achievements to be different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements because they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond MEDIROM’s control and which could, and likely will, affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects MEDIROM’s current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to MEDIROM’s operations, results of operations, growth strategy and liquidity. Some of the factors that could cause actual results to differ materially from those expressed or implied by the forward-looking statements in this press release include: ● MEDIROM’s ability to achieve its development goals for its business and execute and evolve its growth strategies, priorities and initiatives;● changes in Japanese and global economic conditions and financial markets, including their effects on MEDIROM’s expansion in Japan and certain overseas markets;● MEDIROM’s ability to achieve and sustain profitability in its Digital Preventative Healthcare Segment;● the fluctuation of foreign exchange rates, which affects MEDIROM’s expenses and liabilities payable in foreign currencies;● MEDIROM’s ability to maintain and enhance the value of its brands and to enforce and maintain its trademarks and protect its other intellectual property;● MEDIROM’s ability to raise additional capital on acceptable terms or at all;● MEDIROM’s level of indebtedness and potential restrictions on MEDIROM under MEDIROM’s debt instruments;● changes in consumer preferences and MEDIROM’s competitive environment; ● MEDIROM’s ability to respond to natural disasters, such as earthquakes and tsunamis, and to global pandemics, such as COVID-19; and● the regulatory environment in which MEDIROM operates. More information on these risks and other potential factors that could affect MEDIROM’s business, reputation, results of operations, financial condition, and stock price is included in MEDIROM’s filings with the Securities and Exchange Commission (the “SEC”), including in the “Risk Factors” and “Operating and Financial Review and Prospects” sections of MEDIROM’s most recently filed periodic report on Form 20-F and subsequent filings, which are available on the SEC website at www.sec.gov. MEDIROM assumes no obligation to update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ from those anticipated in these forward-looking statements, even if new information becomes available in the future.

MEDIROM MOTHER Labs Provides MOTHER Bracelet®︎ Device and Remote Health Monitoring System, REMONY, to TOPPAN Inc.

<figure><img src="https://images.microcms-assets.io/assets/9edf8dbea622483096fe2cacad989656/c99b3c1bc91f4e71977058b4d58fe909/2201.png" alt="" width="1920" height="1280"></figure> Introducing the Recharge-free Smart Tracker “MOTHER Bracelet®” to Medical Institutions to Support Clinical Research through Healthcare Data. December 13th 2024, Tokyo, Japan: MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) (“MEDIROM”) announces that  its subsidiary MEDIROM MOTHER Labs Inc. has formed a business alliance with 3H Medi Solution Inc. 3H Medi Solution Inc. will act as a distributor for MOTHER Labs’ the recharge-free smart tracker “MOTHER Bracelet®,” promoting its adoption in medical institutions and other relevant organizations. Additionally, MOTHER Labs will provide 3H with healthcare data obtained from “MOTHER Bracelet®”, SDK of “MOTHER Gateway®” (Software development Kit), and the remote health monitoring system “REMONY” to support and enhance clinical research efforts. Background of Distribution Agreement for “MOTHER Bracelet”3H supports the growing trend of at-home trials (remote clinical trials and studies) where participants can engage from their own homes. These trials highlight the importance of wearable devices that can continuously, objectively, and in real-time capture everyday data from patients. This approach is also advancing research on digital biomarkers. On this occasion, both companies shared the vision of supporting researchers and companies dedicated to advancing health through cutting-edge technology for a lot of people. This led to the signing of a distribution agreement for MOTHER Labs’ MOTHER Bracelet. Primary Sales and Utilization Targets・Medical Institutions・Pharmaceutical Company・Clinical Research at universities・Introduction at conferences and related event Future ProspectWhen users wear MOTHER Bracelet® on their wrist, the data from the device is transmitted to Remote Health Monitoring System “REMONY”, via MOTHER Gateway. With “REMONY,” vital data from users can be managed in real-time, enabling the utilization of this data for healthcare-related clinical research. By leveraging 3H’s expertise in data-driven clinical studies and data analysis, we aim to assess future risks associated with diseases. This capability to evaluate disease risk will allow us to provide support in preventing illnesses. Through the partnership between MOTHER Labs and 3H, we aspire to create a world where people can proactively prevent and manage their health. <figure><img src="https://images.microcms-assets.io/assets/9edf8dbea622483096fe2cacad989656/7bd801e1fc01484795764681eea3bf7b/2202.jpg" alt="" width="1920" height="1080"></figure> About 3H Medi Solution Inc.As a life sciences company dedicated to connecting Human Health and Happiness, we offer one-stop services across the pharmaceutical and medical fields, including patient recruitment, surveys, information provision, app and system development, and support for new business development. Through science and patient-centric drug discovery and development support, combined with the latest in digital health transformation technologies, we work to address the needs of patients and healthcare settings.URL：<a href="https://3h-ms.co.jp/">https://3h-ms.co.jp/</a> Forward-Looking Statements Regarding MEDIROMCertain statements in this press release are forward-looking statements for purposes of the safe harbor provisions under the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements may include estimates or expectations about MEDIROM’s possible or assumed operational results, financial condition, business strategies and plans, market opportunities, competitive position, industry environment, and potential growth opportunities. In some cases, forward-looking statements can be identified by terms such as “may,” “will,” “should,” “design,” “target,” “aim,” “hope,” “expect,” “could,” “intend,” “plan,” “anticipate,” “estimate,” “believe,” “continue,” “predict,” “project,” “potential,” “goal,” or other words that convey the uncertainty of future events or outcomes. These statements relate to future events or to MEDIROM’s future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause MEDIROM’s actual results, levels of activity, performance, or achievements to be different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements because they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond MEDIROM’s control and which could, and likely will, affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects MEDIROM’s current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to MEDIROM’s operations, results of operations, growth strategy and liquidity. More information on these risks and other potential factors that could affect MEDIROM’s business, reputation, results of operations, financial condition, and stock price is included in MEDIROM’s filings with the Securities and Exchange Commission (the “SEC”), including in the “Risk Factors” and “Operating and Financial Review and Prospects” sections of MEDIROM’s most recently filed periodic report on Form 20-F and subsequent filings, which are available on the SEC website at www.sec.gov. MEDIROM assumes no obligation to update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ from those anticipated in these forward-looking statements, even if new information becomes available in the future. ABOUT MEDIROM MOTHER Labs Inc.A subsidiary of MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM), focuses on the health-tech sector. The company’s core activities include the &apos;Specific Health Guidance Program&apos; offered through the &apos;Lav&apos; health application and development and sales of the 24/7 recharge-free MOTHER Bracelet smart tracker. By leveraging the features of the recharge-free MOTHER Bracelet, MOTHER Labs offers customizable health management solutions across diverse sectors, including caregiving, logistics, manufacturing, etc. MEDIROM Healthcare Technologies Inc.NASDAQ Symbol: MRMTradepia Odaiba, 2-3-1 Daiba, Minato-ku, Tokyo, JapanWeb <a href="https://medirom.co.jp/en">https://medirom.co.jp/en</a>Contact: ir@medirom.co.jp MEDIROM MOTHER Labs Inc.Tradepia Odaiba, 2-3-1 Daiba, Minato-ku, Tokyo, Japan <figure><img src="https://images.microcms-assets.io/assets/9edf8dbea622483096fe2cacad989656/cd1ccbb1e9404f6d858234d24cabfb7d/1746.jpg" alt="" width="1920" height="1080"></figure> MOTHER Bracelet is the world&apos;s first* 24/7 recharge-free smart tracker. It uses innovative technology from a Silicon Valley tech company that allows for power generation based on temperature differences between body and surrounding air. The recharge-free feature eliminates the risk of data loss when a device is taken off for recharge. MOTHER Bracelet records five basic metrics: heart rate, calories burned, body surface temperature, step count, and sleep. Official Website: <a href="https://mother-bracelet.com">https://mother-bracelet.com</a> <figure><img src="https://images.microcms-assets.io/assets/9edf8dbea622483096fe2cacad989656/62c6cbe9e2254e13a8cfd8d1a7f8f02d/2173.jpg" alt="" width="1920" height="1080"></figure>&apos;REMONY&apos; remote health monitoring system, developed by MEDIROM MOTHER Labs, combines the wrist-worn recharge-free smart tracker MOTHER Bracelet with a dedicated gateway. The system enables automatic data synchronization and centralized real-time management.Health monitoring with conventional wearables often faces challenges due to data loss during device recharge period. However, &apos;MOTHER&apos; measures user vital data in real-time 24/7 without needing removal for recharge. As a result, it allows prompt and early detection of health emergencies and accident prevention with high accuracy.The system is customizable for use in various industries, including elderly care, health monitoring for night shift workers, and etc. Function 1: Measurement and visualization of the heart rate, body surface temperature, step count, sleep, and burned  calories.Function 2: Heart rate alerts with a customizable heart rate threshold settings.Function 3: Automatic SMS notification to a specific phone number in case of alerts.Function 4: Automatic fall detection alert.Function 5: User-triggered emergency SOS alert.

MEDIROM’s subsidy, MEDIROM MOTHER Labs Inc.  Forms a Business Alliance with 3H Medi Solution Inc.

December 9th 2024, Tokyo, Japan: MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) (“MEDIROM”) announces that its subsidiary MEDIROM MOTHER Labs Inc. has received orders for over 25,000 MOTHER Bracelet units, including orders from Japanese companies such as NFES Technologies Inc. “Our long-term mission is for the Mother Bracelet to be revolutionary in the Healthcare Technology and Wellness industries. The 25,000 unit MOTHER Bracelet orders surpasses the amount we’ve received and fulfilled to date and shows the continued momentum of our market penetration. Furthermore, we believe such orders received from not only NFES Technologies but also two other major companies listed on the Tokyo Stock Exchange further validates the commercialization of our technology.” said Kouji Eguchi, CEO, MEDIROM. About MEDIROM Healthcare Technologies Inc.MEDIROM, a holistic healthcare company, operates over 300 wellness salons across Japan, Re.Ra.Ku® being its leading brand, and provides healthcare services. In 2015, MEDIROM entered the health tech business and launched new healthcare programs using an on-demand training app called “Lav®”, which is developed by MEDIROM. MEDIROM also entered the device business in 2020 and has developed a smart tracker “MOTHER Bracelet®”. In 2023, MEDIROM launched REMONY, a remote monitoring system for corporate clients, and has received orders from a broad range of industries, including nursing care, transportation, construction, and manufacturing, among others. MEDIROM hopes that its diverse health-related product and service offerings will help it collect and manage healthcare data from users and customers and enable it to become a leader in big data in the healthcare industry. For more information, visit <a href="https://medirom.co.jp/en.">https://medirom.co.jp/en.</a> Contact:Investor Relations TeamE-mail:ir@medirom.co.jp No Offer or Solicitation This press release and the information contained herein are not, and do not, constitute an offer to sell any securities or a solicitation of an offer to buy any securities in the United States or any other state or jurisdiction, nor shall any securities be offered or sold in any jurisdiction in which such an offer, solicitation or sale would be unlawful. Forward-Looking Statements Regarding MEDIROM  Certain statements in this press release are forward-looking statements for purposes of the safe harbor provisions under the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements may include estimates or expectations about MEDIROM’s possible or assumed operational results, financial condition, business strategies and plans, market opportunities, competitive position, industry environment, and potential growth opportunities. In some cases, forward-looking statements can be identified by terms such as “may,” “will,” “should,” “design,” “target,” “aim,” “hope,” “expect,” “could,” “intend,” “plan,” “anticipate,” “estimate,” “believe,” “continue,” “predict,” “project,” “potential,” “goal,” or other words that convey the uncertainty of future events or outcomes. These statements relate to future events or to MEDIROM’s future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause MEDIROM’s actual results, levels of activity, performance, or achievements to be different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements because they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond MEDIROM’s control and which could, and likely will, affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects MEDIROM’s current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to MEDIROM’s operations, results of operations, growth strategy and liquidity. Some of the factors that could cause actual results to differ materially from those expressed or implied by the forward-looking statements in this press release include: ● MEDIROM’s ability to achieve its development goals for its business and execute and evolve its growth strategies, priorities and initiatives;● changes in Japanese and global economic conditions and financial markets, including their effects on MEDIROM’s expansion in Japan and certain overseas markets;● MEDIROM’s ability to achieve and sustain profitability in its Digital Preventative Healthcare Segment;● the fluctuation of foreign exchange rates, which affects MEDIROM’s expenses and liabilities payable in foreign currencies;● MEDIROM’s ability to maintain and enhance the value of its brands and to enforce and maintain its trademarks and protect its other intellectual property;● MEDIROM’s ability to raise additional capital on acceptable terms or at all;● MEDIROM’s level of indebtedness and potential restrictions on MEDIROM under MEDIROM’s debt instruments;● changes in consumer preferences and MEDIROM’s competitive environment; ● MEDIROM’s ability to respond to natural disasters, such as earthquakes and tsunamis, and to global pandemics, such as COVID-19; and● the regulatory environment in which MEDIROM operates. More information on these risks and other potential factors that could affect MEDIROM’s business, reputation, results of operations, financial condition, and stock price is included in MEDIROM’s filings with the Securities and Exchange Commission (the “SEC”), including in the “Risk Factors” and “Operating and Financial Review and Prospects” sections of MEDIROM’s most recently filed periodic report on Form 20-F and subsequent filings, which are available on the SEC website at www.sec.gov. MEDIROM assumes no obligation to update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ from those anticipated in these forward-looking statements, even if new information becomes available in the future.

MEDIROM Healthcare Technologies  Has Received Orders for Over 25,000 MOTHER Bracelet Units

December 1ST 2024, Tokyo, Japan: MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) (“MED IROM”) announces that M3, Inc. (TOKYO PRIME: 2413), or an affiliate within the M3 group, is participating in the Series A equity financing round of MEDIROM MOTHER Labs Inc., a sub sidiary of MEDIROM. NFES Technologies Inc. is the lead investor of the Series A financing round at a pre-money valuation of JPY9 billion. Additional information is available.here: <a href="https://ir.medirom.co.jp/news/capital-and-business-alliance-formed-between-medirom-mother-labs-and-nfes-technologies/1fcbaa06-103f-4e86-aede-57add01e49e1">https://ir.medirom.co.jp/news/capital-and-business-alliance-formed-between-medirom-mother-labs-and-nfes-technologies/1fcbaa06-103f-4e86-aede-57add01e49e1</a> Forward-Looking Statements Regarding MEDIROMCertain statements in this press release are forward-looking statements for purposes of th e safe harbor provisions under the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements may include estimates or expectations about MEDIROM’s possible or assumed operational results, financial condition, business strategies and plans, market opportunities, competitive position, industry environment, and potential growth opportunit ies. In some cases, forward-looking statements can be identified by terms such as “may,” “will,” “should,” “design,” “target,” “aim,” “hope,” “expect,” “could,” “intend,” “plan,” “anticipate,” “estimate,” “believe,” “continue,” “predic t,” “project,” “potential,” “goal,” or other words that convey the uncertainty of f uture events or outcomes. These statements relate to future events or to MEDIROM’s future financial performance, and involve known and unknown risks, uncertainties and other factor s that may cause MEDIROM’s actual results, levels of activity, performance, or achievemen ts to be different from any future results, levels of activity, performance or achievement s expressed or implied by these forward-looking statements. You should not place undue rel iance on forward-looking statements because they involve known and unknown risks, uncertai nties and other factors which are, in some cases, beyond MEDIROM’s control and which coul d, and likely will, affect actual results, levels of activity, performance or achievement s. Any forward-looking statement reflects MEDIROM’s current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to MEDIROM’s operations, results of operations, growth strategy and liquidity. More information on these risks and other potential factors that could affect MEDIROM’s b usiness, reputation, results of operations, financial condition, and stock price is includ ed in MEDIROM’s filings with the Securities and Exchange Commission (the “SEC”), includ ing in the “Risk Factors” and “Operating and Financial Review and Prospects” sections of MEDIROM’s most recently filed periodic report on Form 20-F and subsequent filings, whi ch are available on the SEC website at www.sec.gov. MEDIROM assumes no obligation to updat e or revise these forward-looking statements for any reason, or to update the reasons actu al results could differ from those anticipated in these forward-looking statements, even i f new information becomes available in the future. ABOUT M3, Inc. M3 is a one of a kind venture company that operates a multitude of global services centred around its physician platform such as m3.com.M3 is the first company incorporated after the year 2000 to be included in the Nikkei 225 Index. Its 330,000+ Japanese and 6,500,000+ global physician member panel serves as a cent ral platform in advancing innovation and reform across healthcare worldwide.Tokyo Stock Exchange Prime Market (Securities code 2413) 1-11-44 Akasaka Minato-ku, Tokyo 107-0052 JAPANWeb <a href="https://corporate.m3.com/en">https://corporate.m3.com/en</a> <figure><img src="https://images.microcms-assets.io/assets/9edf8dbea622483096fe2cacad989656/9ace7fc9752344c8a34a27825646fcd5/1421.png" alt="" width="1428" height="337"></figure> ABOUT MEDIROM MOTHER Labs Inc. A subsidiary of MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM), focuses on the health- tech sector. The company’s core activities include the &apos;Specific Health Guidance Program&apos; offered through the &apos;Lav&apos; health application and development and sales of the 24/7 recharg e-free MOTHER Bracelet smart tracker. By leveraging the features of the recharge-free MOTH ER Bracelet, MOTHER Labs offers customizable health management solutions across diverse se ctors, including caregiving, logistics, manufacturing, etc. MEDIROM Healthcare Technologies Inc.NASDAQ Symbol: MRMTradepia Odaiba, 2-3-1 Daiba, Minato-ku, Tokyo, Japan Web <a href="https://medirom.co.jp/en">https://medirom.co.jp/en</a>Contact: ir@medirom.co.jp MEDIROM MOTHER Labs Inc.Tradepia Odaiba, 2-3-1 Daiba, Minato-ku, Tokyo, Japan <figure><img src="https://images.microcms-assets.io/assets/9edf8dbea622483096fe2cacad989656/cd1ccbb1e9404f6d858234d24cabfb7d/1746.jpg" alt="" width="1920" height="1080"></figure> MOTHER Bracelet is the world&apos;s first* 24/7 recharge-free smart tracker. It uses innovative technology from a Silicon Valley tech company that allows for power generation based on te mperature differences between body and surrounding air. The recharge-free feature eliminat es the risk of data loss when a device is taken off for recharge. MOTHER Bracelet records five basic metrics: heart rate, calories burned, body surface temperature, step count, and sleep. Official Website: <a href="https://mother-bracelet.com">https://mother-bracelet.com</a>

M3 Group Joins MEDIROM Mother Labs’ Series A Financing Round at JPY9 Billion (as of December 1, 2024, approximately USD $59,000,000) Pre-Money Valuation

<figure><img src="https://images.microcms-assets.io/assets/9edf8dbea622483096fe2cacad989656/ad28dc22f38f44649c87372a29104160/2094.png" alt="" width="1920" height="1280"></figure> November 7th 2024, Tokyo, Japan: MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) announced a business alliance with SBC Medical Group Holdings Incorporated (Nasdaq: SBC) a global owner, operator and provider of management services and products to cosmetic treatment centers. Our two leading healthcare service providers have more than 4 million members across their loyalty programs at SBC’s “Shonan Beauty Clinic” and MEDIROM’s “Re.Ra.Ku wellness salon”. In addition to bringing customers enhanced offerings and expertise, the alliance will seek to create compelling, integrated opportunities to harness the power of these loyal customers and reward them when they receive services at SBC Medical and MEDIROM. In this alliance, both companies have elevated expectations for their different customer segments. Shonan Beauty Clinic is widely supported mainly by women in their 20s and 30s, while MEDIROM’s Re.Ra.Ku serves mainly male customers for relaxation and health maintenance. This collaboration is expected to enable the two companies to approach new markets, expand total customer base, and provide new value. “We believe we can provide new value and’Healthy and Beauty Synergies’ by distributing special invitation tickets to customers visiting each store,” said Kouji Eguchi, CEO, MEDIROM. About SBC MedicalSBC Medical, through its subsidiaries, provides services to support the operation of clinics that deliver highly specialized medical services in the areas of cosmetic medicine, esthetic dentistry, and Androgenetic Alopecia or AGA, primarily in Japan and centered on the SBC Shonan Beauty Clinic Brand. SBC Medical and its subsidiaries now provide management services to a total of 224 franchisees located worldwide.　For Global, SBC Medical owns and operates one treatment center in Vietnam and provides management services to one treatment center in State of California in the United States. For more information, visit https://sbc-holdings.com/ Contact: SBC Medical Group Holdings IncorporatedHikaru Fukui / Head of Investor Relations  E-mail: ir@sbc-holdings.com About MEDIROM Healthcare Technologies Inc. MEDIROM, a holistic healthcare company, operates over 300 wellness salons across Japan, Re.Ra.Ku® being its leading brand, and provides healthcare services. In 2015, MEDIROM entered the health tech business and launched new healthcare programs using an on-demand training app called “Lav®”, which is developed by the Company. MEDIROM also entered the device business in 2020 and has developed a smart tracker “MOTHER Bracelet®”. In 2023, MEDIROM launched REMONY, a remote monitoring system for corporate clients, and has received orders from a broad range of industries, including nursing care, transportation, construction, and manufacturing, among others. MEDIROM hopes that its diverse health-related product and service offerings will help it collect and manage healthcare data from users and customers and enable it to become a leader in big data in the healthcare industry. For more information, visit https://medirom.co.jp/en. Contact:Investor Relations TeamE-mail:ir@medirom.co.jp Forward-Looking Statements Regarding MEDIROM  Certain statements in this press release are forward-looking statements for purposes of the safe harbor provisions under the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements may include estimates or expectations about MEDIROM’s possible or assumed operational results, financial condition, business strategies and plans, market opportunities, competitive position, industry environment, and potential growth opportunities. In some cases, forward-looking statements can be identified by terms such as “may,” “will,” “should,” “design,” “target,” “aim,” “hope,” “expect,” “could,” “intend,” “plan,” “anticipate,” “estimate,” “believe,” “continue,” “predict,” “project,” “potential,” “goal,” or other words that convey the uncertainty of future events or outcomes. These statements relate to future events or to MEDIROM’s future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause MEDIROM’s actual results, levels of activity, performance, or achievements to be different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements because they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond MEDIROM’s control and which could, and likely will, affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects MEDIROM’s current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to MEDIROM’s operations, results of operations, growth strategy and liquidity. Some of the factors that could cause actual results to differ materially from those expressed or implied by the forward-looking statements in this press release include: MEDIROM’s ability to achieve its development goals for its business and execute and evolve its growth strategies, priorities and initiatives;MEDIROM’s and  SBC Medical Group’s ability to collaborate in the anticipated manner;changes in Japanese and global economic conditions and financial markets, including their effects on MEDIROM’s expansion in Japan and certain overseas markets;MEDIROM’s ability to achieve and sustain profitability in its Digital Preventative Healthcare Segment;the fluctuation of foreign exchange rates, which affects MEDIROM’s expenses and liabilities payable in foreign currencies;MEDIROM’s ability to maintain and enhance the value of its brands and to enforce and maintain its trademarks and protect its other intellectual property;MEDIROM’s ability to raise additional capital on acceptable terms or at all;MEDIROM’s level of indebtedness and potential restrictions on MEDIROM under MEDIROM’s debt instruments;changes in consumer preferences and MEDIROM’s competitive environment; MEDIROM’s ability to respond to natural disasters, such as earthquakes and tsunamis, and to global pandemics, such as COVID-19; andthe regulatory environment in which MEDIROM operates. More information on these risks and other potential factors that could affect MEDIROM’s business, reputation, results of operations, financial condition, and stock price is included in MEDIROM’s filings with the Securities and Exchange Commission (the “SEC”), including in the “Risk Factors” and “Operating and Financial Review and Prospects” sections of MEDIROM’s most recently filed periodic report on Form 20-F and subsequent filings, which are available on the SEC website at www.sec.gov. MEDIROM assumes no obligation to update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ from those anticipated in these forward-looking statements, even if new information becomes available in the future.

Healthy and Beauty Synergies MEDIROM Healthcare Technologies and SBC Medical Group Holdings Announce Business Alliance

November 1, 2024 ,Tokyo, Japan: MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM), announces the appointment of Issei Homan as Chief Technology Officer(CTO) of the group and Yasuhiro Hayami as Chief Business Officer (CBO) of its subsidiary, MEDIROM MOTHER Labs, Inc. ◾️Background of Management Structure EnhancementThe MEDIROM Group operates more than 300 wellness salons nationwide, centering on Re.Ra.Ku.While the retail business has been the core of its operations, it will enter the IT/device business in earnest in 2020, transforming itself into a health tech company based on &apos;real x IT.&apos;Establishing a CTO and CBO strengthens the overall group structure centered on the health tech division MEDIROM MOTHER Labs, Inc.We are pleased to announce the appointment of two experienced individuals who share the Medirom Group&apos;s corporate philosophy, culture, and vision.We are committed to achieving further growth for the entire group. ◾️Introduction of CTO and CBO <figure><img src="https://images.microcms-assets.io/assets/9edf8dbea622483096fe2cacad989656/ef1de28fce1f4ea2b0342d141b626958/2104.png" alt="" width="1413" height="2000"></figure> Chief Technology Officer(CTO), Medilom GroupIssei Homan Career.May 2007 Establishes Aratana Inc. and assumes the position of Senior Managing DirectorMay 2015 Aratana Inc. becomes a wholly owned subsidiary of Start Today Inc.September 2018 Appointed Manager of Development Department of ZOZOUSED Inc.Oct. 2019 Established Time Design LLC, CEOMar. 2024 Joined Medirom Shared Services Corporation CTO Comment.I belive that six themes are important for people to lead rich lives: clothing, food, housing, learning, recreation, and health.I want to accomplish something related to these themes through work or personal activities.The last theme, &apos;Ken (health),&apos; is significant. As in (clothing, food, shelter, housing, learning, and recreation) x (health), health is a multiplier, and zero health means zero results.I was ignorant about health, so I was in a state of searching for what I should do,I was excited by the Medirom Group&apos;s &apos;healthcare revolution&apos; and saw a future for myself.The Medirom Group has spent more than 20 years focusing on the health prevention business, including relaxation, the MOTHER Bracelet, an intelligent tracker that does not require recharging, and the Lav, a health care application. We will continue to make new changes by taking a more aggressive stance toward the &apos;Healthcare Revolution.In the process of such changes, there are many opportunities to learn and grow from a technological perspective, and I believe it is a privilege to be an engineer to be involved at that time.Technology makes the world more interesting! I would like to continue to push forward with the desire to &apos;make the world more enjoyable through technology! <figure><img src="https://images.microcms-assets.io/assets/9edf8dbea622483096fe2cacad989656/03ebebc72b6a4fdf9c58ddad6cc5a817/2105.png" alt="" width="1413" height="2000"></figure> Chief Business Officer (CBO), MEDIROM MOTHER Labs, Inc.Yasuhiro Hayami Career.1996 Established INIT Co., Ltd. and assumed the position of Representative Director2004 Merged with the Internet division of transcosmos inc. by transferring business rights. Appointed Managing Executive Officer of transcosmos inc.Served as head of sales for the Internet division, head of services, and deputy head of company-wide services, mainly expanding the Internet business. He has also served as a director of many subsidiaries of listed companies in Japan and abroad.2014: Founded Wise, Inc. and assumed the position of Representative DirectorEstablished Japan&apos;s first rehabilitation service not covered by insurance, “Cerebral Infarction Rehabilitation Center,” and expanded its facilities nationwide.2024 Appointed Chairman of the Board of MEDIROM Rehab Solutions, Inc.Serial entrepreneur in various industries including Kids Golf, Tanpac (muscle diner), Dumpling Library, Eagle Capital, Konichi Hello, etc. Appointed as director, board member, advisor, etc. for various corporations. Comment.Upon graduating from university, I encountered the potential of the Internet and started a business from scratch in a 6-mat office. Blessed with many encounters and business partners, I transferred my company to Transcosmos 20 years ago and assumed the position simultaneously. After that, for 10 years as an executive at Transcosmos, I worked with my colleagues to expand the business from 1 billion to 30 billion scale, and in 2013, I ended my life in the Internet business.In 2014, I felt the need for “self-funded rehabilitation,” which had never existed in the world. I launched the “Brain Infarction Rehabilitation Center” with the belief that “self-funded rehabilitation services will become the third option,” taking advantage of the fact that I did not know what was right and left and taking on the challenge of “going from nothing to the norm. This center has been blessed with many people and has 13 facilities nationwide, with approximately 7,000 people using its services.We have now joined the MEDIROM Group together with the Brain Infarction Rehabilitation Center. I have been working on the MOTHER Bracelet, a smart tracker that does not require recharging. This is truly a fusion of IT and healthcare that I have cultivated up to now, and I have a strong desire to “spread this wonderful service further throughout the world.”I am very much looking forward to becoming the CBO of MEDIROM MOTHER Labs, Inc. and expanding the service centered on the “MOTHER Bracelet” domestically and internationally.

Notice of Establishment and Appointment of CTO (Chief Technology Officer) and CBO (Chief Business Officer) to strengthen management structure as a health tech company.

<figure><img src="https://images.microcms-assets.io/assets/9edf8dbea622483096fe2cacad989656/00406d1fef6247c4aa145fab08b70146/2076.png" alt="" width="1920" height="1280"></figure> NOVEMBER 22nd, 2024, Japan: MEDIROM Healthcare technologies Inc. (NASDAQ: MRM), a leading health tech company headquartered in Minato-ku, Tokyo, and led by CEO Kouji Eguchi, announces that its subsidiary, MEDIROM MOTHER Labs Inc. (“MOTHER Labs”), will introduce its smart tracker, &apos;MOTHER Bracelet®,&apos; at the long-term stay hotels &apos;ENT TERRACE&apos;, operated by Lead Real Estate Co., LTD. (NASDAQ: LRE), starting from Friday, November 1st. MOTHER Bracelet®, a smart tracker that does not require recharging 24 hours a day, 365 days a year, will be rented free of charge to the guests staying at ENT TERRACE. In addition to visualizing your own health condition, you can earn energy points just by walking, which can be exchanged for money and donated to support society. Donations will be given to organizations that are working to create and support the future of Japan. The theme of this activity is “Circulation of Happiness through Travel Energy”. Please experience a new style of travel that adds the essence of excitement to your trip by sharing your happy memories with those around you. ◾️Activity Overview “Circulation of Happiness through Energy of Travel” The first step in the beginning will be the introduction to the “ENT TERRACE” series, two apartment hotel locations. The guests who share the vision of this activity will receive a free rental of the MOTHER Bracelet®. The device does not require recharging and is waterproof, allowing guests to take a bath or swim in the pool without any stress. Customers simply wear the device and enjoy their trip, and energy is accumulated based on the number of steps they take, which automatically leads to social support.In addition, the device&apos;s measurement functions of steps, sleep, body surface temperature, heart rate, and calories burned will enable the user to check his/her own vital data from a terminal installed at the front desk. This is a customer-participatory activity that will visualize the state of health and contribute to society at the same time, “creating a cycle of happiness for yourself and society”. <figure><img src="https://images.microcms-assets.io/assets/9edf8dbea622483096fe2cacad989656/f2a37ee521a04eccb2caba077e5b90bf/2077.png" alt="" width="1920" height="1080"></figure> Vital data and accumulated energies are checked at the hotel <figure><img src="https://images.microcms-assets.io/assets/9edf8dbea622483096fe2cacad989656/f640bca538184d6697952a18575bb290/2073.png" alt="" width="1908" height="1280"></figure> ※The images are for illustrative purposes only. 【Start Date】November 1, 2024 (Friday)【Facilities】ENT TERRACE ASAKUSA, ENT TERRACE AKIHABARA, total 2 locations【Content】By using “MOTHER Bracelet®”, 50 yen for every 5,000 steps, up to 100 yen per day, will be exchanged for money and donated by the hotel to organizations that are working to build and support the future of Japan.【How to Participate】Information will be provided by front desk staff upon check-in. 【Participation Fee】Free rental ◾️Outline of Facilities <figure><img src="https://images.microcms-assets.io/assets/9edf8dbea622483096fe2cacad989656/77a9948a42f7408497e89e140aaca018/1998.jpg" alt="" width="1600" height="1067"></figure> ▪Ent Terrace AsakusaLocation: 2-9-13 Kotobuki, Taito-ku, Tokyo 111-0042Access: 1 minute walk from Tawaramachi Station on Tokyo Metro Ginza LineNumber of Guest Rooms: 8 rooms (1 room per floor)Telephone Number: 03-6231-7772Official website: https://ent-terrace.com/asakusa/ <figure><img src="https://images.microcms-assets.io/assets/9edf8dbea622483096fe2cacad989656/235cb527e3674fc8954cf940567dd3ef/1999.jpg" alt="" width="2000" height="1333"></figure> ▪Ent Terrace AkihabaraLocation: 6-3-8 Sotokanda, Chiyoda-ku, Tokyo 101-0021Access: 3 minutes on foot from Suehirocho Station on the Tokyo Metro Ginza LineNumber of Guest Rooms: 8 rooms (1 room per floor)Telephone Number: 03-6803-0237Official Website: <a href="https://ent-terrace.com/akihabara/">https://ent-terrace.com/akihabara/</a> ◾️About Lead Real Estate Co.,LTD.Primarily engaged in luxury real estate planning and development in Tokyo, Kanagawa, and Sapporo, Hokkaido. LRE’s goal is to accurately understand the characteristics and needs of our clients, aiming to create a more comfortable and secure living environment. LRE specializes in the planning and development of luxury homes, condominiums, and single-occupancy residences. With expertise in luxury property development and specialized knowledge in real estate purchasing, LRE provides the best living environment tailored to our clients&apos; needs. For more information please visit LRE’s website: <a href="https://www.lead-real.co.jp/">https://www.lead-real.co.jp/</a><figure><img src="https://images.microcms-assets.io/assets/9edf8dbea622483096fe2cacad989656/dcde1b4c2a7349559d81f31d9f9eb988/2000.png" alt="" width="1428" height="200"></figure> ◾️About the “ENT TERRACE” series ENT TERRACE” is the long-term stay hotel brand operated by Lead Real Estate Co.,LTD. After opening a guesthouse in Komagome in 2019 with the concept of transitioning from &apos;want to stay&apos; to &apos;want to live,&apos; we launched an apartment hotel in Asakusa in 2022 and another in Akihabara in 2023. In 2024, “ENT TERRACE AKIHABARA” received a 9.5 out of 10 customer rating on Booking.com and won the “Traveller Review Awards,” and all of our properties have been certified as Super Hosts on Airbnb. The company will continue to develop its hotels with the aim of providing a space where guests can relax as if they were at home, while ensuring privacy and easing the burden of long-term stays.URL: https: //ent-terrace.com/<figure><img src="https://images.microcms-assets.io/assets/9edf8dbea622483096fe2cacad989656/3d0c08c0299341b29b6596e6b46d5e44/2001.png" alt="" width="2000" height="873"></figure>  《List of facilities》Apartment Hotel: ENT TERRACE ASAKUSA / ENT TERRACE AKIHABARAGuesthouse: ENT TERRACE KOMAGOME / ENT TERRACE HORIKIRI SHOBUEN / ENT TERRACE SHINAGAWA HIGASHI-OI / ENT TERRACE OMORI SANNO KOSHER HOTEL 《SNS》・Instagram：<a href="https://www.instagram.com/entterrace_hotel_official/">https://www.instagram.com/entterrace_hotel_official/</a>・Facebook：<a href="https://www.facebook.com/entterrace.apartmenthotel/">https://www.facebook.com/entterrace.apartmenthotel/</a>・X：<a href="https://x.com/entterracehotel">https://x.com/entterracehotel</a> For more information visit: <a href="https://mother-bracelet.com">https://mother-bracelet.com</a><figure><img src="https://images.microcms-assets.io/assets/9edf8dbea622483096fe2cacad989656/cd1ccbb1e9404f6d858234d24cabfb7d/1746.jpg" alt="" width="1920" height="1080"></figure>

Steps Count While Traveling Lead to Social Support Hotel “ENT TERRACE” guests begin operating “MOTHER Bracelet,”  a smart tracker that does not require recharging～Circulation of “Happiness” with the Energy of Travel～

<figure><img src="https://images.microcms-assets.io/assets/9edf8dbea622483096fe2cacad989656/842204ede6604f969c490d3f12266799/2053.png" alt="" width="1920" height="1280"></figure> OCTOBER 15th, 2024, Tokyo, Japan: MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) announces that its subsidiary MEDIROM MOTHER Labs Inc. has formed a capital and business alliance with Elematec Corporation (TOKYO PRIME: 2715), a member of the Toyota Tsusho Corporation group. Under the capital and business alliance agreement, Elematec Corporation has agreed to make a strategic investment in MEDIROM MOTHER Labs’ Series A round  at a pre-money valuation of 9 billion yen (approximately US$60,000,000, calculated at an exchange rate of JPY150 to US$1). Elematec is an electronics trading company with over 70 locations in Japan and abroad. The Company provides commercial products in various fields, including the latest electronic products such as smartphones, tablets, home appliances, automobiles, OA equipment, and industrial equipment. “We anticipate the capital and business alliance will produce strong synergies with Elematec&apos;s parts procurement and manufacturing services and allow us to leverage its vast network of business partners to provide an additional distribution channel for MEDIROM’s MOTHER Bracelet,” said Yoshio Uekusa, CEO, MEDIROM MOTHER Labs. With demand from Elematec’s customers for new and feature-rich personal electronics, the MOTHER Bracelet offers appealing advanced features that enable customers to monitor their health 24 hours a day, 365 days a year without the need for recharging and allowing for uninterrupted continuous monitoring. About Elematec Corporation <figure><img src="https://images.microcms-assets.io/assets/9edf8dbea622483096fe2cacad989656/cde8fa70b63d4390b7dd8a44557a33c9/2054.png" alt="" width="760" height="320"></figure> Elematec Corporation is an electronics trading company created in 2009 through the integration of Takachiho Electric Co., Ltd. and Onishi Denki Co., Ltd. Since the establishment of Takachiho Electric in 1947, the company has continued to grow while wielding flexibility and speed to earn the trust of customers in the fast-evolving electronics industry. As a partner in manufacturing, the company aligns itself with customers from the starting line of product development and works together with them to realize one-stop solutions by being involved from the planning and development, all the way through design, prototyping, and mass production stages. Through the company’s industry-leading network in Japan and overseas, it delivers products from electronic materials, parts and module products to finished products, on a global scale. Elematec Corporation is a member of the Toyota Tsusho Corporation group, with Toyota Tsusho Corporation being the sole general trading company of the Toyota Group.Web: <a href="https://www.elematec.com/en/">https://www.elematec.com/en/</a> About MEDIROM MOTHER Labs Inc. A subsidiary of MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) (“MEDIROM”), MEDIROM MOTHER Labs Inc. (“MOTHER Labs”) focuses on the health-tech sector. The company’s core activities include the &apos;Specific Health Guidance Program&apos; offered through the &apos;Lav&apos; health application and development and sales of the 24/7 recharge-free MOTHER Bracelet® smart tracker. By leveraging the features of the recharge-free MOTHER Bracelet®, MOTHER Labs offers customizable health management solutions across diverse sectors, including caregiving, logistics, manufacturing, etc.For more information visit: <a href="https://mother-bracelet.com">https://mother-bracelet.com</a> MEDIROM Healthcare Technologies Inc.NASDAQ Symbol: MRMTradepia Odaiba, 2-3-1 Daiba, Minato-ku, Tokyo, JapanWeb <a href="https://medirom.co.jp/en">https://medirom.co.jp/en</a>Contact:  ir@medirom.co.jp MEDIROM MOTHER Labs Inc.Tradepia Odaiba, 2-3-1 Daiba, Minato-ku, Tokyo, Japan Forward-Looking Statements Regarding MEDIROM Healthcare Technologies Inc. and MEDIROM MOTHER Labs Inc. Certain statements in this press release are forward-looking statements for purposes of the safe harbor provisions under the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements may include estimates or expectations about MEDIROM’s possible or assumed operational results, financial condition, business strategies and plans, market opportunities, competitive position, industry environment, and potential growth opportunities. In some cases, forward-looking statements can be identified by terms such as “may,” “will,” “should,” “design,” “target,” “aim,” “hope,” “expect,” “could,” “intend,” “plan,” “anticipate,” “estimate,” “believe,” “continue,” “predict,” “project,” “potential,” “goal,” or other words that convey the uncertainty of future events or outcomes. These statements relate to future events or to MEDIROM’s future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause MEDIROM’s actual results, levels of activity, performance, or achievements to be different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements because they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond MEDIROM’s control and which could, and likely will, affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects MEDIROM’s current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to MEDIROM’s operations, results of operations, growth strategy and liquidity. Some of the factors that could cause actual results to differ materially from those expressed or implied by the forward-looking statements in this press release include: •MEDIROM’s ability to achieve its development goals for its business and execute and evolve its growth strategies, priorities and initiatives;•MEDIROM’s and Elematec Corporation’s ability to collaborate in the anticipated manner;•changes in Japanese and global economic conditions and financial markets, including their effects on MEDIROM’s expansion in Japan and certain overseas markets;•MEDIROM’s ability to achieve and sustain profitability in its Digital Preventative Healthcare Segment;•the fluctuation of foreign exchange rates, which affects MEDIROM’s expenses and liabilities payable in foreign currencies;•MEDIROM’s ability to maintain and enhance the value of its brands and to enforce and maintain its trademarks and protect its other intellectual property;•MEDIROM’s ability to raise additional capital on acceptable terms or at all;•MEDIROM’s level of indebtedness and potential restrictions on MEDIROM under MEDIROM’s debt instruments;•changes in consumer preferences and MEDIROM’s competitive environment;•MEDIROM’s ability to respond to natural disasters, such as earthquakes and tsunamis, and to global pandemics, such as COVID-19; and•the regulatory environment in which MEDIROM operates.More information on these risks and other potential factors that could affect MEDIROM’s business, reputation, results of operations, financial condition, and stock price is included in MEDIROM’s filings with the Securities and Exchange Commission (the “SEC”), including in the “Risk Factors” and “Operating and Financial Review and Prospects” sections of MEDIROM’s most recently filed periodic report on Form 20-F and subsequent filings, which are available on the SEC website at www.sec.gov. MEDIROM assumes no obligation to update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ from those anticipated in these forward-looking statements, even if new information becomes available in the future.

ELEMATEC CORPORATION FORMS A BUSINESS ALLIANCE WITH AND AGREES TO MAKE A STRATEGIC INVESTMENT IN MEDIROM HEALTHCARE TECHNOLOGIES’ MOTHER LABS SUBSIDIARY

Please refer to the attached PDF for details.

MEDIROM GROUP AND LEAD REAL ESTATE HOTELS FORM BUSINESS ALLIANCE

<figure><img src="https://images.microcms-assets.io/assets/9edf8dbea622483096fe2cacad989656/b79fbfcedac1481c87417c4ac2743a6a/2061.png" alt="" width="1920" height="1280"></figure> OCTOBER 7th 2024, Tokyo, Japan: MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) (“Medirom” orthe “Company”) is pleased to announce that it is capitalizing on its extensive experience operating wellnessclinics and Healthcare Technology to expand into the Rehabilitation industry. In doing so, MEDIROMlaunched its subsidiary, Rehab Solutions, and acquired the rehabilitation centers of Y’s, Inc. Y’s, Inc. ownsand operates ten cerebral infarction rehabilitation centers in Tokyo, Japan. Cerebral infarction rehabilitation is a comprehensive program designed to help individuals who haveexperienced various types of strokes. These types of strokes occur when a blood vessel supplying the brainbecomes blocked, leading to tissue damage and potential long-term consequences. Typical components ofcerebral infarction rehabilitation include: Physical therapy, Occupational therapy, Speech therapy, Cognitivetherapy, and Emotional support.  “We are delighted to announce the expansion into Rehabilitation services under Rehab Solutions and theacquisition of Y’s, Inc. We see significant synergies and will leverage our extensive wellness clinic operationalexperience as well as our health-tech capabilities.” Said Kouji Eguchi, CEO, Medirom. ABOUT MEDIROM Rehab Solutions Inc.CEO: Kosuke ItoLocation: 16F, Tradepia Odaiba, 2-3-1 Daiba, Minato-ku, TokyoDate of establishment: June 10, 2024Business description: Operation of “Cerebral Infarction Rehabilitation Center,” an uninsured service, andcontracted rehabilitation servicesPublic Relations: Aiko IdoTEL: 03-5542-0785Email: info@mediromrehabsolutions.jp ABOUT MEDIROM Healthcare Technologies Inc.MEDIROM Healthcare Technologies Inc., together with its subsidiaries, provides holistic health services inJapan. It operates in three segments: Relaxation Salon, Digital Preventative Healthcare, and Luxury Beauty.MEDIROM Healthcare Technologies Inc. was incorporated in 2000 and is headquartered in Tokyo, Japan.NASDAQ Symbol: MRMTradepia Odaiba, 2-3-1 Daiba, Minato-ku, Tokyo, Japan<a href="https://medirom.co.jp/en">https://medirom.co.jp/en</a>Contact: ir@medirom.co.jp

HIGHLIGHTS

SERVICE